Dataset Information


Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.

ABSTRACT: Graft-versus-host disease (GVHD) continues to be a serious complication that limits the success of allogeneic bone marrow transplantation (BMT). Using IL-7-deficient murine models, we have previously shown that IL-7 is necessary for the pathogenesis of GVHD. In the present study, we determined whether GVHD could be prevented by antibody-mediated blockade of IL-7 receptor alpha (IL-7Ralpha) signaling. C57/BL6 (H2K(b)) recipient mice were lethally irradiated and underwent cotransplantation with T-cell-depleted (TCD) BM and lymph node (LN) cells from allogeneic BALB/c (H2K(d)) donor mice. Following transplantation, the allogeneic BMT recipients were injected weekly with either anti-IL-7Ralpha antibody (100 mug per mouse per week) or PBS for 4 weeks. Anti-IL-7Ralpha antibody treatment significantly decreased GVHD-related morbidity and mortality compared with placebo (30% to 80%). IL-7Ralpha blockade resulted in the reduction of donor CD4(+) or CD8(+) T cells in the periphery by day 30 after transplantation. Paradoxically, the inhibition of GVHD by anti-IL-7Ralpha antibody treatment resulted in improved long-term thymic and immune function. Blockade of IL-7R by anti-IL-7Ralpha antibody resulted in elimination of alloreactive T cells, prevention of GVHD, and improvement of donor T-cell reconstitution.


PROVIDER: S-EPMC2018665 | BioStudies | 2007-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3058832 | BioStudies
2012-01-01 | S-EPMC3373011 | BioStudies
1000-01-01 | S-EPMC2676099 | BioStudies
2013-01-01 | S-EPMC3863612 | BioStudies
1000-01-01 | S-EPMC2886094 | BioStudies
2018-01-01 | S-EPMC5919881 | BioStudies
1000-01-01 | S-EPMC2686147 | BioStudies
1000-01-01 | S-EPMC3258603 | BioStudies
2011-01-01 | S-EPMC3117905 | BioStudies
2013-01-01 | S-EPMC4011929 | BioStudies